MCF Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.9K Buy
886
+249
+39% +$7.96K ﹤0.01% 698
2025
Q4
$12.9K Buy
637
+314
+97% +$7.59K ﹤0.01% 775
2025
Q3
$9.73K Buy
+323
New +$6.99K ﹤0.01% 702
2024
Q2
Sell
-203
Closed -$2.52K 1026
2024
Q1
$2.52K Hold
203
﹤0.01% 792
2023
Q4
$5.39K Sell
203
-162
-44% -$4.72K ﹤0.01% 670
2023
Q3
$16.7K Hold
365
﹤0.01% 510
2023
Q2
$15.1K Hold
365
﹤0.01% 512
2023
Q1
$11.3K Buy
+365
New +$11.8K ﹤0.01% 552

Other funds holding AEHR

MCF Advisors's AEHR Position: Q1 2026 in Review

MCF Advisors increased its Aehr Test Systems (AEHR) stake by 39% in Q1 2026, buying an estimated $7.96K and bringing the position to 886 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #698.

MCF Advisors first reported a position in AEHR in Q1 2023 and has held it in 8 quarters since. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • MCF Advisors held 886 shares of Aehr Test Systems worth $32.9K as of Q1 2026.
  • MCF Advisors bought 249 Aehr Test Systems shares in Q1 2026, an estimated $7.96K.
  • Aehr Test Systems made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #698 holding.
  • MCF Advisors first reported a position in Aehr Test Systems in Q1 2023 and has held it in 8 quarters since.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.